141 related articles for article (PubMed ID: 29737401)
1. Transplantation of adipose tissue-derived stem cells ameliorates autoimmune pathogenesis in MRL/lpr mice : Modulation of the balance between Th17 and Treg.
Zhang W; Feng YL; Pang CY; Lu FA; Wang YF
Z Rheumatol; 2019 Feb; 78(1):82-88. PubMed ID: 29737401
[TBL] [Abstract][Full Text] [Related]
2. [Adipose tissue derived stem cells'treatment effects in MRL/lpr mice and its effects on the imbalance of Th17/Treg cells].
Zhang W; Pang CY; Wang YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):974-978. PubMed ID: 29263467
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus.
Wei S; Xie S; Yang Z; Peng X; Gong L; Zhao K; Zeng K; Lai K
Lupus; 2019 Feb; 28(2):199-209. PubMed ID: 30572770
[TBL] [Abstract][Full Text] [Related]
4. Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus.
He X; Zhang Y; Zhu A; Zeng K; Zhang X; Gong L; Peng Y; Lai K; Qu S
Immunol Res; 2016 Dec; 64(5-6):1157-1167. PubMed ID: 27617336
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice.
Zhou K; Zhang H; Jin O; Feng X; Yao G; Hou Y; Sun L
Cell Mol Immunol; 2008 Dec; 5(6):417-24. PubMed ID: 19118507
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of Adipose Tissue-Derived Mesenchymal Stem Cells Prevents the Development of Lupus Dermatitis.
Choi EW; Shin IS; Song JW; Yun TW; Yang J; Choi KS; Seong JK
Stem Cells Dev; 2015 Sep; 24(17):2041-51. PubMed ID: 25941899
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
8. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
10. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
[TBL] [Abstract][Full Text] [Related]
11. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
Zhang Z; Liu D; Zhang X; Wang X
Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
[TBL] [Abstract][Full Text] [Related]
14. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
Zhang GF; Zhang X; Dong GF
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
[TBL] [Abstract][Full Text] [Related]
17.
Kim DS; Park Y; Choi JW; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():696074. PubMed ID: 34956169
[TBL] [Abstract][Full Text] [Related]
18. SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.
Gatto M; Luisetto R; Ghirardello A; Cavicchioli L; Codolo G; Biasiolo A; Maggioni G; Saccon F; Beggio M; Cappon A; Venturini R; Pontisso P; Doria A
Front Immunol; 2018; 9():2081. PubMed ID: 30254646
[No Abstract] [Full Text] [Related]
19. Immune therapeutic potential of stem cells from human supernumerary teeth.
Makino Y; Yamaza H; Akiyama K; Ma L; Hoshino Y; Nonaka K; Terada Y; Kukita T; Shi S; Yamaza T
J Dent Res; 2013 Jul; 92(7):609-15. PubMed ID: 23697344
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
